Have you seen the latest content on Cystic Fibrosis News Today?

Cystic Fibrosis Weekly Update Contents: S. pseudopneumoniae Bacteria Can Cause Pulmonary Exacerbations in CF Patients, Study Finds FDA Grants Priority Review to ARV-1801, Potential Antibiotic for Pulmonary Flares in CF S. pseudopneumoniae Bacteria Can Cause Pulmonary Exacerbations in CF Patients, Study Finds Jan 31, 2020 07:00 am | Marta Figueiredo Streptococcus pseudopneumoniae should be included in the panel of opportunistic bacteria causing pulmonary exacerbations among those with cystic fibrosis (CF), according to a small French study. The study, “Streptococcus pseudopneumoniae, an opportunistic pathogen in patients with cystic fibrosis,” was published in the Journal of Cystic Fibrosis. S. pseudopneumoniae is a recently described species of bacteria […] The post S. pseudopneumoniae Bacteria Can Cause Pulmonary Exacerbations in CF Patients, Study Finds appeared first on Cystic Fibrosis News Today. Read More FDA Grants Priority Review to ARV-1801, Potential Antibiotic for Pulmonary Flares in CF Jan 30, 2020 07:00 am | Vanessa Pataia Arrevus announced that the U.S. Food and Drug Administration (FDA) has given a form of priority review to ARV-1801 (sodium fusidate tablets), a potential oral treatment of pulmonary exacerbations in people with cystic fibrosis (CF). A clinical trial in patients is in planning stages, the company added in a press release. This designation came in the form of […] The post FDA Grants Priority Review to ARV-1801, Potential Antibiotic for Pulmonary Flares in CF appeared first on Cystic Fibrosis News Today. Read More Recent News Antibiotic Combination Kills Resistant Bacteria Affecting CF Patients, Study Reports I Am Out of the Hospital and Can’t Write My Column Underweight CF Patients Have Lung Transplant Survival Rates Comparable to Recipients With Other Lung Conditions, Study Reports So This Is How My Life Is Now Proteostasis On Track to Develop Organoids for Personalized Medicine Strategy for CF Patients with Rare Mutations